Key facts
- Notable investors include Koinz Capital.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Botanicca
- ·The full record, as it builds
Funding rounds
No funding rounds for Botanicca are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Botanicca
Operator of a natural wellness brand intended to provide quality medicinal mushroom extracts and botanical derivatives that support mental and physical health. The company offers potent, natural and vegan extracts sourced from controlled origins, enabling customers to improve focus, boost energy levels, strengthen immunity and achieve better relaxation through science-backed functional fungi.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Dover, DE, United States
- Founded
- 2024
- Website
- botanicca.com/
- Ownership
- Privately Held (backing)
Botanicca doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Botanicca shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Botanicca in its N-PORT filings yet. We sweep new filings monthly.